Axogen Q1 revenue $48.6M (+17.4% YoY); appoints Lindsey Hartley as CFO

Axogen, Inc.

2025-Q1 EPS reported -$0.08 revenue$48,560,000

Q1 revenue $48.6M, up 17.4% YoY; net loss $3.8M ($0.08/share) vs $6.6M loss in Q1 2024.
Adjusted net loss $0.9M ($0.02/share) vs $2.7M loss; adjusted EBITDA $2.9M vs $1.0M prior year.
Gross margin 71.9% down from 78.8% due to product costs and inventory write-offs; cash $28.1M.
CFO Nir Naor steps down May 11; Lindsey Hartley appointed effective May 12; salary $440k, target bonus 50%.
FY guidance maintained: revenue growth 15-17%, gross margin 73-75%, net cash flow positive.

item 2.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Lindsey Hartley

Chief Financial Officer

AXGN · Axogen, Inc.

Effective: 2025-05-12
Filed: May 8, 2025, 7:59 PM ET

On May 8, 2025, Axogen, Inc. (the “Company”) announced the appointment of Lindsey Hartley as its Chief Financial Officer, effective May 12, 2025

Departed

Nir Naor

Chief Financial Officer

AXGN · Axogen, Inc.

Effective: 2025-05-11
Successor: Lindsey Hartley
Filed: May 8, 2025, 7:59 PM ET

Nir Naor, the Chief Financial Officer (the “CFO”) of the Company, will step down from his role effective May 11, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lindsey Hartley was appointed as Chief Financial Officer at Axogen, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On May 8, 2025, Axogen, Inc. (the “Company”) announced the appointment of Lindsey Hartley as its Chief Financial Officer, effective May 12, 2025

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Nir Naor departed as Chief Financial Officer at Axogen, Inc..

Action: stepped down
Role: Chief Financial Officer

Exact text from the filing

Nir Naor, the Chief Financial Officer (the “CFO”) of the Company, will step down from his role effective May 11, 2025

View on SEC.gov

Axogen, Inc. filing history →

Source: SEC EDGAR

accession 0000805928-25-000062

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.